Aluminum-Based Metal−Organic Framework Nanoplatform Combines Chemo-Nanotherapy in an Intrahepatic Walker 256 Rat Tumor Model: Association with Glycerophospholipid Metabolic Changes
Molecular Pharmaceutics · 03.11.2026
DOI: 10.1021/acs.molpharmaceut.6c00927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 03.11.2026. Verfasst von Jinyu Ji und 6 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, Key Scientific Research Project of Colleges and Universities in Henan Province, Henan Provincial Health Commission and the Ministry.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) treatment is severely limited by the low efficacy and drug resistance of current monotherapies. While nanocarriers for sorafenib (Sor) delivery have been explored, platforms that combine multimodal therapy and elucidate deep-seated anti-tumor mechanisms remain lacking. To address this, we engineered a nanosystem by loading Sor onto an aluminum-based metal−organic framework (Sor@Al-MOF), which combines chemotherapy with the intrinsic bioactivity of the nanocarrier. Sor@Al-MOF nanoparticles exhibited a well-defined lamellar structure, with a zeta potential of 10.10 ± 0.69 mV. Sor@Al-MOF achieved a high drug loading content (56.43% ± 0.36%) and encapsulation efficiency (77.38% ± 4.20%), and exhibited a cumulative release of 65.74 ± 0.55% at pH 5.3 after 72 h. In vitro, Sor@Al-MOF showed potent cytotoxicity against human HCC HepG2 cells (IC50 = 88.40 ± 0.12 μg/mL). In an intrahepatic Walker 256 rat tumor model, Sor@Al-MOF demonstrated enhanced therapeutic efficacy. Integrated metabolomics provided preliminary insights into potential metabolic changes in this model, including changes in choline kinase α (CHKα)-related glycerophospholipid metabolism. This study presents Sor@Al-MOF as a promising combinatorial nanotherapeutic candidate and offers a foundational basis for exploring metabolism-targeting strategies in liver cancer treatment.
Förderung
- Natural Science Foundation of Henan Province
- Key Scientific Research Project of Colleges and Universities in Henan Province
- Henan Provincial Health Commission and the Ministry
- Henan Province Health Science and Technology Innovation Youth Talent Project
Zitieren
APA
Ji, J., Wang, X., Shi, Y., Jing, Z., Sun, Z., Zhao, S., & Du, Q. (2026). Aluminum-Based Metal−Organic Framework Nanoplatform Combines Chemo-Nanotherapy in an Intrahepatic Walker 256 Rat Tumor Model: Association with Glycerophospholipid Metabolic Changes. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00927
Vancouver
Ji J, Wang X, Shi Y, Jing Z, Sun Z, Zhao S, et al. Aluminum-Based Metal−Organic Framework Nanoplatform Combines Chemo-Nanotherapy in an Intrahepatic Walker 256 Rat Tumor Model: Association with Glycerophospholipid Metabolic Changes. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.6c00927
BibTeX
@article{Ji2026,
author = {Ji, Jinyu and Wang, Xiaohui and Shi, Yingying and Jing, Ziwei and Sun, Zhi and Zhao, Songfeng and Du, Qiuzheng},
title = {Aluminum-Based Metal−Organic Framework Nanoplatform Combines Chemo-Nanotherapy in an Intrahepatic Walker 256 Rat Tumor Model: Association with Glycerophospholipid Metabolic Changes},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.6c00927}
}
EUVIMED